News & Updates

Patients who had been infected with COVID-19 continue to experience symptoms at medium-term follow-up, showing greater high-sensitivity C-reactive protein (hsCRP) than controls, results of a study have shown.

Individuals with inflammatory bowel disease (IBD) appear to be at greater risk of developing chronic obstructive pulmonary disease (COPD) and asthma, suggests a study.

A remotely delivered structured weight management programme appears effective and safe in reducing symptoms that matter most among individuals with long COVID (LC) and overweight, findings from the wait-list-controlled open-label ReDIRECT trial suggest.